5 Results for "

chemotherapy-resistant

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "chemotherapy-resistant" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-109050
CAS No.: 1637771-14-2
Purity:  98.04%
Synonyms: GS-5829
Research Areas:  

Cancer

Alobresib (GS-5829) is a BET bromodomain inhibitor, which represents a highly effective therapeutics agent against recurrent/chemotherapy resistant uterine serous carcinoma (USC) overexpressing c-Myc. Alobresib can be used in the metastatic castration-resistant prostate cancer (mCRPC) research .
loading...
    loading...
Cat. No.: HY-156816
CAS No.: 1585246-23-6
Purity:  99.73%
Synonyms: 108600
Research Areas:  

Cancer

ON 108600 (108600) is a CK2 (CK2α1: IC50 = 50 nM; CK2α2 = 5 nM), TNIK (IC50 = 5 nM) and DYRK (DYRK1A: IC50 = 16 nM; DYRK1B = 7 nM; DYRK2: = 28 nM). ON 108600 suppresses the growth of CD44high/CD24low breast cancer stem cell (BCSC) populations, induces G2/M arrest and apoptosis in triple negative breast cancer (TNBC) cells, and inhibits tubulin polymerization. ON 108600 can be used for the study of chemotherapy-resistant and metastatic TNBC .
loading...
    loading...
Cat. No.: HY-14688
CAS No.: 374071-46-2
Target:  

PARP

Research Areas:  

Cancer

CEP-8983 is a PARP-1 and PARP-2 inhibitor (IC50: 20 and 6 nM). CEP-8983 is an effective chemosensitizing agent, and can sensitize chemotherapy-resistant cell lines and subcutaneous xenografts to Temozolomide (HY-17364) and Camptothecin (HY-16560) .
loading...
    loading...
Cat. No.: HY-P991545

Target:  

CD20

Research Areas:  

Cancer

BVX20 is a human monoclonal antibody that binds to CD20. BVX20 can kill B-cells through recruiting the immune system. BVX20 can be studied in research for relapsed or chemotherapy-resistant follicular B-cell NHL and CD20-positive diffuse large B-cell NHL .
loading...
    loading...
Cat. No.: HY-109050R
CAS No.: 1637771-14-2
Synonyms: GS-5829 (Standard)
Research Areas:  

Cancer

Alobresib (Standard) is the analytical standard of Alobresib (HY-109050). This product is intended for research and analytical applications. Alobresib (GS-5829) is a BET bromodomain inhibitor, which represents a highly effective therapeutics agent against recurrent/chemotherapy resistant uterine serous carcinoma (USC) overexpressing c-Myc. Alobresib can be used in the metastatic castration-resistant prostate cancer (mCRPC) research .
loading...
    loading...